RXi Pharmaceuticals Corp 4
4 · RXi Pharmaceuticals Corp · Filed Apr 26, 2017
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Stock option (right to buy)
2017-04-24+95,000→ 95,000 totalExercise: $0.65Exp: 2027-04-24→ Common stock (95,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.